Fidelis Capital Partners, LLC Cara Therapeutics, Inc. Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 25,403 shares of CARA stock, worth $6,604. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,403Holding current value
$6,604% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
102Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$889,5540.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.48MShares$645,1270.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$471,9150.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$442,5480.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$404,6250.01% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $14M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...